Handelsavisen
prelaunch
Companies Financials 082640.KS
08
082640.KS KRX Insurance

Tongyang Life Insurance Co Ltd

$8 200,00
Open in Charts → Attach watcher ⌖
KRW
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
1,28T KRW
P/E
EV / Rev
Div yield
0,00 %
Op margin
ROE
8,0 %
Net margin
Debt / equity
0,81
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Tongyang Life Insurance Co Ltd operates as a multiline insurance provider within the Financials sector, generating revenue through insurance premiums and investment income.

Business. Tongyang Life Insurance Co Ltd (082640.KS) is a South Korean insurance company operating within the Financials sector. The firm is engaged in multiline insurance and brokerage activities. It is headquartered in South Korea and is primarily listed on the Korea Exchange (KRX). Specific details regarding operating segments or geographic revenue breakdowns are not available.

Classification58 %
SectorFinancials
Business sectorInsurance
ActivityMultiline Insurance & Brokers
Generated · model-assisted
Sell-side consensus
BUY2 analysts
1 buy1 hold0 sell
Avg 12m price target7 350,00

Analyst recommendations

2 analysts · consensus Buy
Buy1
Hold1
Sell0
12-month price target
7 350,00
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
2 analysts · indicative
Ownership
not yet wired
Profitability
8,0 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 082640.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials · THIS SECTOR−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 082640.KS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Tongyang Life Insurance Co Ltd (082640.KS) is a South Korean insurance company operating within the Financials sector. The firm is engaged in multiline insurance and brokerage activities. It is headquartered in South Korea and is primarily listed on the Korea Exchange (KRX). Specific details regarding operating segments or geographic revenue breakdowns are not available.

    Classification58 %
    SectorFinancials
    Business sectorInsurance
    ActivityMultiline Insurance & Brokers
    AI synthesis
    GENERATED

    Tongyang Life Insurance Co Ltd maintains a capital structure characterized by high leverage typical of the insurance industry, with total liabilities of 33.8 trillion KRW against total equity of 1.55 trillion KRW. The debt-to-equity ratio stands at 0.81, reflecting significant long-term debt of 1.25 trillion KRW. Liquidity is assessed as medium risk, with cash and equivalents totaling 250.4 billion KRW. Operating cash flow is robust at 2.65 trillion KRW, but free cash flow is constrained to 135.4 billion KRW after capital expenditures of 15.3 billion KRW. The company holds a net negative cash position when total debt is subtracted from liquid assets, a key flag in the risk assessment.

    Profitability metrics indicate modest returns on capital. Return on equity is 8.04%, while return on assets is 0.35%. The company generated net income of 124.5 billion KRW on operating income of 138.8 billion KRW. Valuation multiples suggest the market prices the stock at a discount to book value, with a price-to-book ratio of 0.75 and a price-to-tangible-book ratio of 0.75. The price-to-earnings ratio is 9.29, and the EV/EBITDA multiple is 15.53. These figures reflect a mature business with stable but low-growth profitability characteristics.

    Segment and geographic data are not provided in the current input, preventing a detailed analysis of revenue concentration or regional exposure. The company is identified as a multiline insurer, implying diversification across life and potentially non-life products, but specific revenue mixes are absent from the available data.

    Growth trajectory analysis is limited due to the absence of historical period data in the input. Without five-year annual or eight-quarter quarterly revenue and net income trends, it is not possible to assess the direction or acceleration of top-line or bottom-line growth. The current financial snapshot provides a static view of performance without temporal context for trend reasoning.

    Risk factors include medium liquidity risk and low dilution risk. The key flag of negative net cash after debt subtraction highlights balance sheet sensitivity. Dilution risk is low, supported by the fact that basic and diluted shares outstanding are identical at 156.1 million shares, indicating no significant options or convertible securities currently impacting share count. The absence of strong buy analyst recommendations further suggests a cautious market outlook.

    Recent events are reflected in analyst estimates, with a mean price target of 7,350 KRW and a median target of 7,350 KRW. The high target is 8,000 KRW, and the low is 6,700 KRW. The mean recommendation is 2.50, indicating a neutral stance, with one buy rating and one hold rating among analysts. There are no strong buy recommendations. These signals suggest limited near-term upside consensus from the sell side.

    Key takeaways
    • The company trades at a 25% discount to book value (P/B 0.75), suggesting potential undervaluation or market concerns about asset quality.
    • High leverage (D/E 0.81) and negative net cash position create medium liquidity risk, though operating cash flow remains strong at 2.65 trillion KRW.
    • Dilution risk is low, with no difference between basic and diluted share counts, indicating stable equity structure.
    • Analyst sentiment is neutral (mean rec 2.50), with price targets clustered around the current market price of 7,410 KRW.
    • Profitability is modest with an ROE of 8.04% and ROA of 0.35%, typical for mature insurance carriers.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $8 200,00
    Market cap
    $1.16T
    Enterprise value
    $2.16T
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    0.8x
    P / B
    0.8x
    P / Tangible book
    0.8x
    Tangible book
    $1.55T
    Net cash
    -$999.93B
    Current ratio
    Debt / equity
    0.8
    ROA
    0.4%
    ROE
    8.0%
    Cash conversion
    2125.0%
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Life & Group Insurance
    low · llm_fanout_v2
    Life Insurance
    low · llm_fanout_v2

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    1 443,00
    Predicted surprise
    -0,08
    Beat probability
    45 %
    Analysts
    2
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-07-09 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution2 analysts
    Strong buy0
    Buy1
    Hold1
    Sell0
    Strong sell0
    12-month price target$8 000,00 · Median $8 000,00
    Low $8 000,00High $8 000,00

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$6 700,00
    Mean$7 350,00
    Median$7 350,00
    High$8 000,00
    Spot$8 200,00
    −10.4 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    ROE8,0 %Below median
    D/E0,81Bottom quartile
    Cash Conv21,25Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    • Reference data
    How metrics are computed
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    • Return On Assets
      net_income / total_assets
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    Source documents
    • Tongyang Life Insurance Co Ltd Market data — financials · 2026-07-09
    • Tongyang Life Insurance Co Ltd Market data — analyst estimates · 2026-07-09

    Ownership & reference

    Leadership

    • Mun Gu LeePresident, Chief Executive Officer, Director

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    082640.KSCanonical
    KRX · KRW

    Intel & risk

    PredictorBeat prob45 %Surprise-0,08Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data Premium coverage